The ESMO Trials That Got It Right ++++++ ++ +++

Common Sense in Oncology The ESMO Trials That Got It Right https://www.medscape.com/viewarticle/beyond-critique-esmo-trials-got-it-right-2025a1000tsz?ecd=mkm_ret_251116_mscpmrk_onc_perspectives_etid7877089&uac=148436CN&impID=7877089 Interpreting Clinical Research with Bishal Gyawali What Do P Values Really Mean? https://www.medscape.com/viewarticle/skills-lab-what-do-p-values-really-mean-2025a1000sa6?ecd=mkm_ret_251116_mscpmrk_onc_perspectives_etid7877089&uac=148436CN&impID=7877089 Lewis on Oncology Finding Meaning Amid Burnout in Oncology https://www.medscape.com/viewarticle/rediscovering-purpose-hardest-moments-cancer-care-2025a1000tt1?ecd=mkm_ret_251116_mscpmrk_onc_perspectives_etid7877089&uac=148436CN&impID=7877089 Kris on Oncology Neoadjuvant Therapy in NSCLC: Nivolumab’s Curative Potential https://www.medscape.com/viewarticle/neoadjuvant-therapy-nsclc-5-year-study-unveils-nivolumabs-2025a1000sfi?ecd=mkm_ret_251116_mscpmrk_onc_perspectives_etid7877089&uac=148436CN&impID=7877089 Markman on Oncology Social Media’s Influence on Overdiagnosis https://www.medscape.com/viewarticle/health-hype-social-media-test-ads-push-benefits-hide-2025a1000rf8?ecd=mkm_ret_251116_mscpmrk_onc_perspectives_etid7877089&uac=148436CN&impID=7877089 Markman on Oncology HPV Vax Shows Long-Term Cancer Benefits https://www.medscape.com/viewarticle/routine-childhood-hpv-vaccinations-demonstrate-striking-long-2025a1000pf0?ecd=mkm_ret_251116_mscpmrk_onc_perspectives_etid7877089&uac=148436CN&impID=7877089 Practice Essentials ALL: Latest Treatments & Guidelines https://emedicine.medscape.com/article/207631-overview?ecd=mkm_ret_251116_mscpmrk_onc_perspectives_etid7877089&uac=148436CN&impID=7877089 Multiple Myeloma: Approach Considerations You Need to Know https://emedicine.medscape.com/article/204369-overview?ecd=mkm_ret_251116_mscpmrk_onc_perspectives_etid7877089&uac=148436CN&impID=7877089 US Drug Spotlight Cemiplimab https://reference.medscape.com/drug/libtayo-cemiplimab-1000263?ecd=mkm_ret_251116_mscpmrk_onc_perspectives_etid7877089&uac=148436CN&impID=7877089 Durvalumab https://reference.medscape.com/drug/imfinzi-durvalumab-1000145?ecd=mkm_ret_251116_mscpmrk_onc_perspectives_etid7877089&uac=148436CN&impID=7877089 Ibrutinib https://reference.medscape.com/drug/imbruvica-ibrutinib-999896?ecd=mkm_ret_251116_mscpmrk_onc_perspectives_etid7877089&uac=148436CN&impID=7877089